首页 正文

New therapies in multiple myeloma: benefits and limitations

{{output}}
Multiple myeloma (MM) is a bone marrow cancer caused by the clonal proliferation of plasma cells and is classified as a plasma cell dyscrasia. Over the last 20 years, there has been a dramatic increase in the availability of new therapies for patients with MM ... ...